Clinical trial
Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation
NCT00375323 · Medical University of Vienna, Other · Completed
Key facts
| NCT number | NCT00375323 |
|---|---|
| Title | Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation |
| Official title | Effects of Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation in Patients With Hemophilia A and Antibodies to Factor VIII |
| Lead sponsor | Medical University of Vienna, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hemophilia A |
| Intervention type | Drug |
| Interventions | NovoSeven |
| First posted | Sep 12, 2006 |
| Last update posted | Apr 20, 2007 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: